InterOcean Capital LLC Acquires 169 Shares of UnitedHealth Group Inc (NYSE:UNH)

InterOcean Capital LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 16.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,184 shares of the healthcare conglomerate’s stock after acquiring an additional 169 shares during the quarter. InterOcean Capital LLC’s holdings in UnitedHealth Group were worth $295,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of UNH. Country Trust Bank increased its position in shares of UnitedHealth Group by 556.3% during the 1st quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 89 shares during the last quarter. Tobias Financial Advisors Inc. purchased a new position in shares of UnitedHealth Group in the 4th quarter worth about $29,000. RMR Wealth Builders bought a new position in UnitedHealth Group during the fourth quarter valued at about $29,000. HBC Financial Services PLLC purchased a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Finally, Lion Street Advisors LLC bought a new stake in UnitedHealth Group in the first quarter worth about $31,000. 87.10% of the stock is currently owned by institutional investors and hedge funds.

NYSE:UNH traded up $3.03 during mid-day trading on Friday, hitting $289.94. 2,907,540 shares of the stock traded hands, compared to its average volume of 4,276,896. The business’s 50-day moving average price is $277.58 and its 200 day moving average price is $277.14. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.60. The company has a market cap of $272.10 billion, a PE ratio of 20.29, a price-to-earnings-growth ratio of 1.41 and a beta of 0.72. UnitedHealth Group Inc has a 12-month low of $187.72 and a 12-month high of $306.71.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.63 by $0.09. The firm had revenue of $64.40 billion during the quarter, compared to the consensus estimate of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $3.73 EPS. Analysts anticipate that UnitedHealth Group Inc will post 16.24 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 45,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total value of $13,194,113.07. Following the sale, the director now owns 1,013,122 shares of the company’s stock, valued at approximately $292,903,701.42. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total value of $1,060,000.00. Following the sale, the director now owns 158,598 shares of the company’s stock, valued at approximately $33,622,776. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 65,637 shares of company stock valued at $17,723,013. 0.80% of the stock is owned by company insiders.

A number of research analysts have recently weighed in on UNH shares. Deutsche Bank reduced their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research report on Thursday, April 16th. SunTrust Banks increased their price objective on UnitedHealth Group from $340.00 to $360.00 and gave the company a “buy” rating in a report on Thursday. Raymond James lowered their target price on UnitedHealth Group from $340.00 to $325.00 in a research note on Thursday, April 16th. Barclays reiterated a “buy” rating and set a $322.00 price target on shares of UnitedHealth Group in a research note on Sunday, March 29th. Finally, Morgan Stanley lifted their price objective on UnitedHealth Group from $289.00 to $371.00 and gave the stock an “overweight” rating in a report on Thursday, April 30th. Four investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $319.68.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: What is the cash asset ratio?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News